Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2016-06-15 17:17:07
Reporting Period:
Filing Date:
Accepted Time:
2016-06-15 17:17:07
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1232524 Jazz Pharmaceuticals Plc JAZZ Pharmaceutical Preparations (2834) 981032470
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1639637 L. Karen Smith Connaught House, 1 Burlington Rd, Fl. 4
Dublin 4 L2
Global Head Of R&d And Cmo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2016-06-13 557 $149.61 12,994 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. Reflects purchases of ordinary shares executed in multiple transactions at prices ranging from $149.54 to $150.28. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were made.
  3. Includes 38 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 31, 2016.